vs

Side-by-side financial comparison of Arcosa, Inc. (ACA) and AVIENT CORP (AVNT). Click either name above to swap in a different company.

AVIENT CORP is the larger business by last-quarter revenue ($760.6M vs $716.7M, roughly 1.1× Arcosa, Inc.). Arcosa, Inc. runs the higher net margin — 7.3% vs 2.2%, a 5.0% gap on every dollar of revenue. On growth, Arcosa, Inc. posted the faster year-over-year revenue change (7.6% vs 1.9%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $55.8M). Over the past eight quarters, Arcosa, Inc.'s revenue compounded faster (9.4% CAGR vs -4.2%).

Arcosa, Inc. is a provider of infrastructure-related products and solutions operating across three core segments: construction, energy, and transportation. It offers products including utility structures, construction aggregates, and transportation components, primarily serving customers across the North American market to support critical infrastructure development projects.

Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.

ACA vs AVNT — Head-to-Head

Bigger by revenue
AVNT
AVNT
1.1× larger
AVNT
$760.6M
$716.7M
ACA
Growing faster (revenue YoY)
ACA
ACA
+5.7% gap
ACA
7.6%
1.9%
AVNT
Higher net margin
ACA
ACA
5.0% more per $
ACA
7.3%
2.2%
AVNT
More free cash flow
AVNT
AVNT
$69.6M more FCF
AVNT
$125.4M
$55.8M
ACA
Faster 2-yr revenue CAGR
ACA
ACA
Annualised
ACA
9.4%
-4.2%
AVNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACA
ACA
AVNT
AVNT
Revenue
$716.7M
$760.6M
Net Profit
$52.1M
$16.9M
Gross Margin
22.9%
30.2%
Operating Margin
11.0%
5.2%
Net Margin
7.3%
2.2%
Revenue YoY
7.6%
1.9%
Net Profit YoY
776.6%
-65.0%
EPS (diluted)
$1.06
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACA
ACA
AVNT
AVNT
Q4 25
$716.7M
$760.6M
Q3 25
$797.8M
$806.5M
Q2 25
$736.9M
$866.5M
Q1 25
$632.0M
$826.6M
Q4 24
$666.2M
$746.5M
Q3 24
$640.4M
$815.2M
Q2 24
$664.7M
$849.7M
Q1 24
$598.6M
$829.0M
Net Profit
ACA
ACA
AVNT
AVNT
Q4 25
$52.1M
$16.9M
Q3 25
$73.0M
$32.6M
Q2 25
$59.7M
$52.6M
Q1 25
$23.6M
$-20.2M
Q4 24
$-7.7M
$48.3M
Q3 24
$16.6M
$38.2M
Q2 24
$45.6M
$33.6M
Q1 24
$39.2M
$49.4M
Gross Margin
ACA
ACA
AVNT
AVNT
Q4 25
22.9%
30.2%
Q3 25
24.1%
30.4%
Q2 25
22.5%
32.1%
Q1 25
19.8%
31.8%
Q4 24
19.3%
34.8%
Q3 24
21.3%
32.1%
Q2 24
20.8%
30.3%
Q1 24
18.6%
33.6%
Operating Margin
ACA
ACA
AVNT
AVNT
Q4 25
11.0%
5.2%
Q3 25
14.1%
8.3%
Q2 25
12.9%
11.1%
Q1 25
8.8%
0.1%
Q4 24
6.5%
11.5%
Q3 24
5.3%
9.5%
Q2 24
10.1%
8.5%
Q1 24
8.9%
11.3%
Net Margin
ACA
ACA
AVNT
AVNT
Q4 25
7.3%
2.2%
Q3 25
9.2%
4.0%
Q2 25
8.1%
6.1%
Q1 25
3.7%
-2.4%
Q4 24
-1.2%
6.5%
Q3 24
2.6%
4.7%
Q2 24
6.9%
4.0%
Q1 24
6.5%
6.0%
EPS (diluted)
ACA
ACA
AVNT
AVNT
Q4 25
$1.06
$0.18
Q3 25
$1.48
$0.36
Q2 25
$1.22
$0.57
Q1 25
$0.48
$-0.22
Q4 24
$-0.16
$0.53
Q3 24
$0.34
$0.41
Q2 24
$0.93
$0.36
Q1 24
$0.80
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACA
ACA
AVNT
AVNT
Cash + ST InvestmentsLiquidity on hand
$214.6M
Total DebtLower is stronger
$1.5B
$1.9B
Stockholders' EquityBook value
$2.6B
$2.4B
Total Assets
$5.0B
$6.0B
Debt / EquityLower = less leverage
0.57×
0.81×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACA
ACA
AVNT
AVNT
Q4 25
$214.6M
Q3 25
$220.0M
Q2 25
$189.7M
Q1 25
$167.9M
Q4 24
$187.3M
Q3 24
$756.8M
Q2 24
$103.7M
Q1 24
$176.5M
Total Debt
ACA
ACA
AVNT
AVNT
Q4 25
$1.5B
$1.9B
Q3 25
$1.6B
$2.0B
Q2 25
$1.7B
$2.0B
Q1 25
$1.7B
$2.1B
Q4 24
$1.7B
$2.1B
Q3 24
$1.2B
$2.1B
Q2 24
$699.9M
$2.1B
Q1 24
$600.6M
$2.1B
Stockholders' Equity
ACA
ACA
AVNT
AVNT
Q4 25
$2.6B
$2.4B
Q3 25
$2.6B
$2.4B
Q2 25
$2.5B
$2.4B
Q1 25
$2.5B
$2.3B
Q4 24
$2.4B
$2.3B
Q3 24
$2.4B
$2.4B
Q2 24
$2.4B
$2.3B
Q1 24
$2.4B
$2.3B
Total Assets
ACA
ACA
AVNT
AVNT
Q4 25
$5.0B
$6.0B
Q3 25
$5.1B
$6.1B
Q2 25
$5.0B
$6.1B
Q1 25
$4.9B
$5.8B
Q4 24
$4.9B
$5.8B
Q3 24
$4.4B
$6.0B
Q2 24
$3.8B
$5.9B
Q1 24
$3.7B
$5.9B
Debt / Equity
ACA
ACA
AVNT
AVNT
Q4 25
0.57×
0.81×
Q3 25
0.61×
0.83×
Q2 25
0.67×
0.86×
Q1 25
0.68×
0.90×
Q4 24
0.69×
0.89×
Q3 24
0.51×
0.88×
Q2 24
0.29×
0.90×
Q1 24
0.25×
0.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACA
ACA
AVNT
AVNT
Operating Cash FlowLast quarter
$120.0M
$167.8M
Free Cash FlowOCF − Capex
$55.8M
$125.4M
FCF MarginFCF / Revenue
7.8%
16.5%
Capex IntensityCapex / Revenue
9.0%
5.6%
Cash ConversionOCF / Net Profit
2.30×
9.93×
TTM Free Cash FlowTrailing 4 quarters
$175.5M
$195.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACA
ACA
AVNT
AVNT
Q4 25
$120.0M
$167.8M
Q3 25
$160.6M
$72.1M
Q2 25
$61.2M
$112.8M
Q1 25
$-700.0K
$-51.1M
Q4 24
$248.2M
$122.6M
Q3 24
$135.0M
$71.1M
Q2 24
$38.3M
$105.9M
Q1 24
$80.5M
$-42.8M
Free Cash Flow
ACA
ACA
AVNT
AVNT
Q4 25
$55.8M
$125.4M
Q3 25
$121.0M
$47.4M
Q2 25
$33.4M
$85.8M
Q1 25
$-34.7M
$-63.6M
Q4 24
$194.9M
$81.5M
Q3 24
$100.6M
$46.1M
Q2 24
$-9.3M
$74.5M
Q1 24
$26.1M
$-67.2M
FCF Margin
ACA
ACA
AVNT
AVNT
Q4 25
7.8%
16.5%
Q3 25
15.2%
5.9%
Q2 25
4.5%
9.9%
Q1 25
-5.5%
-7.7%
Q4 24
29.3%
10.9%
Q3 24
15.7%
5.7%
Q2 24
-1.4%
8.8%
Q1 24
4.4%
-8.1%
Capex Intensity
ACA
ACA
AVNT
AVNT
Q4 25
9.0%
5.6%
Q3 25
5.0%
3.1%
Q2 25
3.8%
3.1%
Q1 25
5.4%
1.5%
Q4 24
8.0%
5.5%
Q3 24
5.4%
3.1%
Q2 24
7.2%
3.7%
Q1 24
9.1%
2.9%
Cash Conversion
ACA
ACA
AVNT
AVNT
Q4 25
2.30×
9.93×
Q3 25
2.20×
2.21×
Q2 25
1.03×
2.14×
Q1 25
-0.03×
Q4 24
2.54×
Q3 24
8.13×
1.86×
Q2 24
0.84×
3.15×
Q1 24
2.05×
-0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACA
ACA

Engineered Structures$301.1M42%
Total Construction Materials$276.8M39%
Specialty Materials And Asphalt$110.2M15%
Construction Site Support$28.6M4%

AVNT
AVNT

Color Additives And Inks$466.0M61%
Specialty Engineered Materials$295.5M39%

Related Comparisons